isbufylline has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonelli, T; Bacciarelli, C; Ballati, L; Beani, L; Borea, PA; Giachetti, A; Manzini, S; Meini, S | 1 |
Abelli, L; Evangelista, S; Manzini, S; Page, CP; Perretti, F; Seeds, EA | 1 |
2 other study(ies) available for isbufylline and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Pharmacodynamic profile of isbufylline, a new antibronchospastic xanthine devoid of central excitatory actions.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Anticonvulsants; Blood Pressure; Brain Chemistry; Bronchial Spasm; Bronchodilator Agents; Electroencephalography; Female; Gastrointestinal Transit; Guinea Pigs; Hemodynamics; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Myenteric Plexus; Parasympatholytics; Phosphodiesterase Inhibitors; Platelet Activating Factor; Rats; Rats, Inbred Strains; Receptors, Purinergic; Sleep; Trachea | 1990 |
Isbufylline, a new xanthine derivative, inhibits airway hyperresponsiveness and airway inflammation in guinea pigs.
Topics: 1-Methyl-3-isobutylxanthine; Acetylcholine; Albuterol; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Capsaicin; Dextrans; Dyspnea; Fluorescein-5-isothiocyanate; Guinea Pigs; Histamine; Leukocytes; Male; Ovalbumin; Platelet Activating Factor | 1993 |